The discovery of stem cell has revolutionized the medical world. Ever since the pioneering work of Canadian scientists, Dr. James Till and Dr. Ernest McCulloch, stem cell research has opened up doors to treatments for seemingly incurable conditions and set the groundwork for regenerative medicine.

The field presents immense potential as the world regenerative medicine market is expected to reach nearly USD 39 billion by 2021. Nonetheless, research translation has been slow. Up until today, few commercialized and clinically proven products of stem cell are available for patients due to the long and costly research processes, along with several technical challenges. It is important that appropriate investment and resources are streamlined to where the sector needs the most while knowledge sharing and collaboration are fostered among stem cell stakeholders.

With an aim to support stem cell translation and to help scientists, researchers, and industry members to stay ahead of this constantly evolving field, Clariden Global is proud to present Stem Cells and Regenerative Medicine Global Summit in Toronto, Canada, from 25^th – 27^th September 2017.

The summit will showcase the latest innovations and breakthroughs in stem cell research and medical applications around the world. You will have the opportunity to discover the solutions to your technical challenges in stem cell expansion, delivery, and integration. The summit will also address rejection and tumor risks of stem cell therapy, and how to improve the quality of stem cell research. With an international speaker line-up and a global audience base, the event presents a premium platform for all participants to exchange knowledge and discover development progress of stem cell medical treatments that you just cannot miss.

Mark your calendar and stay on top of the stem cell revolution!

6 CRUCIAL STRATEGIES TO STAY AHEAD OF THE STEM CELL MEDICAL REVOLUTION

1. Discover the latest innovative tools in stem cell research, such as Machine Learning, CRISPR, and 3D printing
2. Learn about the new achievements in tissue engineering
3. Unveil solutions to expansion, delivery, and integration challenges
4. Explore new methods to address tumor and rejection risk of stem cell therapies
5. Discover emerging stem cell therapeutic applications and medical progress of stem cell therapies
6. Accelerate commercialization of treatments through tight-knit collaboration among experts across sectors over the world

• Kerry Bowman
  Clinical Ethicist
  Mount Sinai Hospital

• Norman N. Iscove
  Professor
  University of Toronto

• Sara Vasconcelos
  Assistant Scientist, Division of Experimental Therapeutics
  General Research Institute, University Health Network

• Bayer
• Merk
• CSL Behring
• RepliCel
• RegenaStem
• Neuralstem
• CellsforLife
• NanoCellect
• Asymptote
• ORIG3N
• NovaHep
• Atara Biotherapeutics
• ExCellThera
• Octane
• International Stem Cell
• AmGen
• Applikon
• Aspect Biosystem
• Athersys
• Avrobio
• BD
• Janssen
• Cellular Dynamics
• GE Healthcare
• Hemostemix
• Pfizer
• Northern Therapeutics
• Thermo Fisher
• SynGen